HIV-IT immunotherapeutic, a retroviral vector delivering the genes for the HIV env and rev proteins: Phase II Update

Chiron Corp. (CHIR), Emeryville, Calif.
Product: HIV-IT immunotherapeutic,

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE